Cart
sales@molnova.com
7-Methoxy obtusifolin
CAS No. 1820806-09-4
7-Methoxy obtusifolin( ——— )
Catalog No. M38225 CAS No. 1820806-09-4
7-Methoxy obtusifolin (Compound 4) is a competitive tyrosinase inhibitor with an IC50 of 7.0 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name7-Methoxy obtusifolin
-
NoteResearch use only, not for human use.
-
Brief Description7-Methoxy obtusifolin (Compound 4) is a competitive tyrosinase inhibitor with an IC50 of 7.0 μM.
-
Description7-Methoxy obtusifolin (Compound 4) is a competitive tyrosinase inhibitor with an IC50 of 7.0 μM.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorIC50: 7.0 μM (Tyrosinase)
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1820806-09-4
-
Formula Weight314.29
-
Molecular FormulaC17H14O6
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lee GY, et al. Tyrosinase inhibitory components from the seeds of Cassia tora. Arch Pharm Res. 2018 May;41(5):490-496.?
molnova catalog
related products
-
Ufenamate
Ufenamate is an anthranilic acid-based anti-inflammatory drug developed for skin diseases.
-
JR14a
JR14a is a potent antagonist of human complement C3a receptor.
-
Biotin-Atrial Natriu...
Biotin-Atrial Natriuretic Peptide (1-28), human, porcine
